Clearside Biomedical Valuation
| CLSD Stock | USD 1.00 0.01 0.99% |
Today, the firm appears to be fairly valued. Clearside Biomedical shows a prevailing Real Value of $0.98 per share. The current price of the firm is $1.0. Our model approximates the value of Clearside Biomedical from analyzing the firm fundamentals such as operating margin of (5.72) %, and Return On Equity of -13.1 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Clearside Biomedical's price fluctuation is extremely dangerous at this time. Calculation of the real value of Clearside Biomedical is based on 3 months time horizon. Increasing Clearside Biomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Clearside stock is determined by what a typical buyer is willing to pay for full or partial control of Clearside Biomedical. Since Clearside Biomedical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Clearside Stock. However, Clearside Biomedical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0 | Real 0.98 | Hype 1.0 | Naive 1.18 |
The real value of Clearside Stock, also known as its intrinsic value, is the underlying worth of Clearside Biomedical Company, which is reflected in its stock price. It is based on Clearside Biomedical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Clearside Biomedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Clearside Biomedical helps investors to forecast how Clearside stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Clearside Biomedical more accurately as focusing exclusively on Clearside Biomedical's fundamentals will not take into account other important factors: Clearside Biomedical Total Value Analysis
Clearside Biomedical is currently projected to have valuation of 53.8 M with market capitalization of 76.6 M, debt of 43 M, and cash on hands of 29.03 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Clearside Biomedical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
53.8 M | 76.6 M | 43 M | 29.03 M |
Clearside Biomedical Investor Information
About 20.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings (P/E) ratio of 130.0. Clearside Biomedical recorded a loss per share of 0.45. The entity had not issued any dividends in recent years. Clearside Biomedical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Clearside Biomedical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Clearside Biomedical has an asset utilization ratio of 24.18 percent. This indicates that the Company is making $0.24 for each dollar of assets. An increasing asset utilization means that Clearside Biomedical is more efficient with each dollar of assets it utilizes for everyday operations.Clearside Biomedical Ownership Allocation
Clearside Biomedical holds a total of 75.84 Million outstanding shares. Clearside Biomedical shows 7.76 percent of its outstanding shares held by insiders and 20.11 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Clearside Biomedical Profitability Analysis
The company reported the previous year's revenue of 8.23 M. Net Loss for the year was (32.48 M) with profit before overhead, payroll, taxes, and interest of 7.7 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Clearside Biomedical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Clearside Biomedical and how it compares across the competition.
About Clearside Biomedical Valuation
The stock valuation mechanism determines Clearside Biomedical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Clearside Biomedical. We calculate exposure to Clearside Biomedical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Clearside Biomedical's related companies.Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia. Clearside Biomedi operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people.
Clearside Biomedical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Clearside Biomedical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 61.8 M |
Complementary Tools for Clearside Stock analysis
When running Clearside Biomedical's price analysis, check to measure Clearside Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearside Biomedical is operating at the current time. Most of Clearside Biomedical's value examination focuses on studying past and present price action to predict the probability of Clearside Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearside Biomedical's price. Additionally, you may evaluate how the addition of Clearside Biomedical to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |